首页> 外文期刊>Chinese journal of digestive diseases >Spontaneous bacterial peritonitis associated with experimental cirrhosis: Comparative effect of different therapeutic options on endotoxinemia and hemodynamlc derangement
【24h】

Spontaneous bacterial peritonitis associated with experimental cirrhosis: Comparative effect of different therapeutic options on endotoxinemia and hemodynamlc derangement

机译:自发性细菌性腹膜炎与实验性肝硬化:不同治疗方法对内毒素血症和血液动力学紊乱的比较作用

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of this investigation was to assess the role of different therapeutic options aimed at modifying the gut microecology in experimental liver cirrhosis in view of the cytokine cascade and splanchnic and systemic hemodynamics.METHODS: Cirrhosis was induced in male Sprague-Dawley rats by carbon tetrachloride (CCL4). After the 6th week of CCL4 administration rats were divided into 5 groups for the remaining 6 weeks: (A) saline b.i.d; (B) lactulose 0.5 g b.i.d.; (C) rifaximine 1 mg b.i.d; (D) 2 mL b.i.d of a probiotic mixture and (E) 1 week of rifaximine followed by 5 weeks of probiotic.RESULTS: Rats with cirrhosis and ascites showed a significantly high concentration of either portal, splanchnic and systemic endotoxin, as well as plasma TNF-a concentration (P<0.05). Rifaximine alone, rifaximine plus probiotic or probiotic alone significantly decreased the plasma endotoxin concentration at each of the three tested sites, as well as the plasma concentration of TNF-a (P< 0.01). Total Gram-negative aerobic bacteria count in the stool markedly decreased together with a significant increase of the enterococcal population in the rifaximine plus probiotic group and, to a lesser extent, in the other treatment groups.
机译:目的:本研究旨在根据细胞因子级联以及内脏和全身血流动力学,评估旨在改变肠道微生态学在实验性肝硬化中的不同治疗方法的作用。方法:雄性Sprague-Dawley大鼠可诱发肝硬化四氯化碳(CCL4)。在施用CCL4的第6周后,在剩余的6周内将大鼠分为5组:(A)生理盐水。 (B)乳果糖0.5 g b.i.d .; (C)利福昔明1 mg b.i.d; (D)服用2 mL益生菌混合物,(E)服用利福昔明1周,然后服用5周益生菌。结果:肝硬化和腹水大鼠的门静脉内脏,内脏和全身内毒素以及血浆均显着升高TNF-α浓度(P <0.05)。单独使用利福昔明,利福昔明加益生菌或单独使用益生菌可显着降低三个测试位点的血浆内毒素浓度以及TNF-α的血浆浓度(P <0.01)。利福昔明加益生菌组的粪便中总革兰氏阴性需氧菌计数显着下降,肠球菌数量显着增加,而其他治疗组则较小。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号